Pharma Market Access Insights - from Mtech Access
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access - Powered by Petauri.
Podcasting since 2020 • 62 episodes
Pharma Market Access Insights - from Mtech Access
Latest Episodes
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the NHS in England? In July 2024, Global Whispe...
•
Season 7
•
Episode 20
•
56:15
NHS primary care panel – the GP Contract and Operational Planning Guidance
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–...
•
Season 7
•
Episode 19
•
1:02:14
Engage NHS healthcare decision-makers with RWD
Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a w...
•
Season 7
•
Episode 18
•
20:55
Market access and reimbursement in Canada – changes at CADTH
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Gl...
•
Season 5
•
Episode 17
•
47:43
Rare Disease market access in the MENA and Nordic regions
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you loo...
•
Season 5
•
Episode 16
•
59:10